异思氨酸不会增加炎症性肠病的风险:一个TrinetX回顾性队列分析
长期治疗的异丁并不增加患炎症性肠病 (IBD) 的风险. 这项研究没有发现异二胺使用与IBD或性结肠炎之间有显著的关联,以及克罗恩氏病风险降低.
科学领域:
- 皮肤病学 皮肤病学
- 胃肠病学 胃肠病学
- 药学流行病学 药学流行病学
背景情况:
- 人们对异三胺的长期使用和炎症性肠病 (IBD) 风险存在担忧.
- 治疗方法,包括异氨酸,需要对潜在的胃肠道副作用进行安全评估.
研究的目的:
- 调查异二胺治疗与IBD发病率之间的关联.
- 评估使用异二胺治疗的患者患克罗恩病和性结肠炎的风险.
主要方法:
- 使用TrinetX真实世界数据库进行回顾性队列研究.
- 倾向性得分匹配 (1:1) 与暴露于异丁和未暴露的患者进行比较.
- 随访时间为6-10年,以确定IBD发病率.
主要成果:
- 没有观察到与异二胺的IBD (HR:0.88) 或性结肠炎 (HR:1.05) 的风险增加.
- 克罗恩氏病风险降低 (HR:0.69) 与异二胺使用有关.
- 刺激性肠综合征和便calprotectin水平没有显著差异;发生过渡性脂质升高.
结论:
- 长期治疗的异氨酸与IBD风险增加无关.
- 这些发现表明,与患者的IBD发展有关的异丁的安全概况.
更多相关视频
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
09:44Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
